Work location : Shikoku district - Ehime
Date of publication : 2024/07/23
D124071850
Optieum Biotechnologies Inc.
Research field : Life Science - Molecular biology
Research/Educational Assistance : Regular employee - Tenured - Non-tenure track - Probationary period present
Job description
Background of the recruitment and description of the project
Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company founded in June 2020. Our antibody screening platform technology known as the ‘Eumbody System’, enables to develop and detect optimized ScFV CAR-T cells that are highly effective for a specific cancer target. We are actively conducting research with our platform technology to develop CAR-T cells as our primary modality.
Work content and job description
Will be engaged in experimental work for the platform technology, the ‘Eumbody System’ that enhances the function of CAR-T cells.
Key activities for this position are:
-PCR, Cloning, ABI sequencing
-Develop and maintain cell lines
-Maintain good communication and coordination
-Enthusiastic to complete other tasks as needed
Assigned department
Existing departments
Eumbody/Platform Group(Research and Development Department)
Job type
Research field
Wages
Annual Salary : 4 million yen ~ 5 million yen
We will determine based on your previous salary.
Working hours
Working hours :08:30-17:30
Break time :12:00-13:00
Holidays : Saturday, Sunday, public holiday and paid vacation
Application requirements
Qualifications
Education and Degree Requirements
Master
Work experience
- MS in Life Science with at least 1 year of work experience in molecular biology/genetics.
- Experienced in DNA/ RNA extraction, PCR, cloning.
- Experienced with mammalian cell culture.
- Good in everyday communication in both English and Japanese.
- A fast learner with self-motivation.
- Interested in immunotherapy for intractable diseases (especially cancer)
We kindly request that applications be submitted only by individuals who are currently residing in Japan.
Description
We are seeking for highly motivated candidates in our Eumbody/Platform Group to support our experimental work related to scFV library development and to assist in identifying new scFVs to increase our capabilities.
This role will also play a vital part in supporting the development of antigen presenting cells (APC).
Direct experience and knowledge in molecular biology and cell culture techniques are essential.
We kindly request that applications be submitted only by individuals who are currently residing in Japan.
Employment Type
Regular employee
Full-time
Contract period
Tenured - Non-tenure track
Probationary period present
Trial period 6 months.
Work location
Compensation
Various systems
Pay increase system : available
Bonus : Based on the company's performance
Transportation expenses : available
Insurance
Employees' Health Insurance : available
Employees' Pension Insurance : available
Worker's accident insurance : available
Employment insurance : available
Application Considerations
Number of hired
1 person(s)
Job content supplemental explanation
[Description of the institution (year of establishment, capital amount, number of employees, etc.), details of the business, recruitment background information, project description, etc.]
Optieum Biotechnologies Inc. is a biotech company rooted in Ehime, founded on June 30th 2020, aiming to develop optimized CAR-T cells for cancer treatment. The company has forte on its platform technology "Eumbody System" which enables the high-throughput screening for scFv that leads to optimize CAR-T cells antitumor effect.
[Starting date, employment date, etc.]
To be discussed
Application period
2024/07/23~2024/11/21 Deadline for receipt
Application method
Attached documents
Other online application forms
To apply for this opportunity, please send your resume and cover letter. Along with your basic information please note your technical skills.
Return of application documents
We will dispose of all application documents responsibly.
* Out of application period.
URL of this job posting
Selection / Notification of result
Selection
First Round: Examination of documents
Second Round: Interviews, 2-3 times
Notification of result
Results to be informed by e-mail
Contact details
Optieum Biotechnologies Inc.
corporate
Hinako Osawa
08045996630
hinako.osawa@optieumbio.com
Notes